Search research articles
Contact Us
Filters
Showing results (131-140 of 220) with videos related to
Page
of 22
Sort By:
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
December 1, 1994
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs
J L Montastruc, M Lapeyre-Mestre, M E Llau, et al.
European Journal of Pharmacology
|
July 4, 1998
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release
C Allal, E Lazartigues, M A Tran, et al.
Clinical Neuropharmacology
|
December 1, 1987
Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin
O Rascol, M A Tran, P Bonnevialle, et al.
Neurology
|
April 1, 1990
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243)
G Durrieu, J M Senard, O Rascol, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 4, 1998
Prevalence of orthostatic hypotension in Parkinson's disease
J M Senard, S Raï, M Lapeyre-Mestre, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 22, 1999
Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks
I Loubinoux, K Boulanouar, J P Ranjeva, et al.
Archives of Neurology
|
February 1, 1992
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine
O Rascol, U Sabatini, F Chollet, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 3, 1999
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
E Bezard, C Brefel, F Tison, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 1, 1993
Effect of side and rate of stimulation on cerebral blood flow changes in motor areas during finger movements in humans
U Sabatini, F Chollet, O Rascol, et al.
Advances in Neurology
|
January 1, 1996
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients
O Rascol, A J Lees, J M Senard, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 220) with videos related to
Sort By:
Page
of 22
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
December 1, 1994
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs
J L Montastruc, M Lapeyre-Mestre, M E Llau, et al.
European Journal of Pharmacology
|
July 4, 1998
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release
C Allal, E Lazartigues, M A Tran, et al.
Clinical Neuropharmacology
|
December 1, 1987
Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin
O Rascol, M A Tran, P Bonnevialle, et al.
Neurology
|
April 1, 1990
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243)
G Durrieu, J M Senard, O Rascol, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 4, 1998
Prevalence of orthostatic hypotension in Parkinson's disease
J M Senard, S Raï, M Lapeyre-Mestre, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 22, 1999
Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks
I Loubinoux, K Boulanouar, J P Ranjeva, et al.
Archives of Neurology
|
February 1, 1992
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine
O Rascol, U Sabatini, F Chollet, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 3, 1999
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
E Bezard, C Brefel, F Tison, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 1, 1993
Effect of side and rate of stimulation on cerebral blood flow changes in motor areas during finger movements in humans
U Sabatini, F Chollet, O Rascol, et al.
Advances in Neurology
|
January 1, 1996
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients
O Rascol, A J Lees, J M Senard, et al.
Page
of 22